Skip to main content
. 2021 Sep 30;36(5):e305. doi: 10.5001/omj.2022.34

Table 5. Relationship between different parameters with depression and anxiety symptoms.

Parameters Depression (n = 31) Anxiety (n = 25)
n (%) p-value n (%) p-value
Gender
Male (n = 61) 4 (6.6) 0.802 2 (3.3) 0.279
Female (n = 300) 27 (9.0) 23 (7.7)
Marital status
Married (n = 275) 19 (6.9) 0.127 16 (5.8) 0.013
Single (n = 65) 10 (15.4) 5 (7.7)
Divorced (n = 11) 1 (9.1) 4 (36.4)
Widowed (n = 10) 1 (10.0) 0 (0.0)
Education
Primary (n = 40) 3 (7.5) 0.012 1 (2.5) 0.353
Secondary (n = 178) 8 (4.5) 11 (6.2)
Tertiary (n = 128) 17 (13.3) 11 (8.6)
No formal education (n = 15) 3 (20.0) 2 (13.3)
Occupation
Employed (n =188) 19 (10.1) 0.283 16 (8.5) 0.216
Unemployed (n = 173) 12 (6.9) 9 (5.2)
Comorbidities
At least one (n = 178) 16 (9.0) 0.788 11 (6.2) 0.582
None (n = 183) 15 (8.2) 14 (7.7)
Rheumatic disease
SLE (n = 125) 12(9.6) 0.882 11 (8.8) 0.499
RA (n = 150) 12 (8.0) 10(6.7)
Others (n = 86) 7 (8.1) 4 (4.7)
DMARDs
csDMARDs (n = 465) 31 (6.7) 0.727 25 (5.4) 0.707
ts+bDMARDs (n = 25) 3 (12.0) 1 (4.0)

SLE: systemic lupus erythematosus; RA: rheumatoid arthritis; csDMARDs: conventional synthetic disease-modifying anti-rheumatic drugs; bDMARDS: biological disease-modifying anti-rheumatic drugs; tsDMARDs: targeted synthetic disease-modifying anti-rheumatic drugs.